Detalles de la búsqueda
1.
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial.
Circulation
; 148(8): 651-660, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603600
2.
Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.
Am Heart J
; 271: 38-47, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38401646
3.
Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification.
Diabet Med
; 41(2): e15200, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37578188
4.
Diagnostic and prognostic biomarkers for tubulointerstitial fibrosis.
J Physiol
; 601(14): 2801-2826, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227074
5.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis
; 82(1): 84-96.e1, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889425
6.
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE.
Cardiovasc Diabetol
; 22(1): 100, 2023 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120538
7.
Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial.
Cardiovasc Diabetol
; 22(1): 176, 2023 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37438734
8.
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.
Cardiovasc Diabetol
; 22(1): 330, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38017482
9.
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials.
Diabetes Obes Metab
; 25(8): 2151-2162, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37161691
10.
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
J Am Soc Nephrol
; 33(4): 850-866, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361724
11.
Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice.
Int J Mol Sci
; 24(3)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769148
12.
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial.
Circulation
; 143(18): 1735-1749, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33554616
13.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
N Engl J Med
; 380(24): 2295-2306, 2019 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30990260
14.
KCa3.1 in diabetic kidney disease.
Curr Opin Nephrol Hypertens
; 31(1): 129-134, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34710887
15.
Factors Associated With Advanced Colorectal Neoplasia in Patients With CKD.
Am J Kidney Dis
; 79(4): 549-560, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461168
16.
Low-dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity-related chronic kidney disease.
Diabetes Obes Metab
; 24(10): 1939-1949, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35635331
17.
Effects of air pollution on human health - Mechanistic evidence suggested by in vitro and in vivo modelling.
Environ Res
; 212(Pt C): 113378, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35525290
18.
Risk factors for incident kidney disease in older adults: an Australian prospective population-based study.
Intern Med J
; 52(5): 808-817, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33012112
19.
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.
J Ren Nutr
; 32(4): e1-e14, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364782
20.
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
Eur Heart J
; 42(48): 4891-4901, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423370